219 related articles for article (PubMed ID: 38906524)
1. Metabolic Reprogramming in Tumor Immune Microenvironment: Impact on Immune Cell Function and Therapeutic Implications.
Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
Cancer Lett; 2024 Jun; ():217076. PubMed ID: 38906524
[TBL] [Abstract][Full Text] [Related]
2. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
4. Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors.
Liu J; Wang T; Zhang W; Huang Y; Wang X; Li Q
Oncol Res Treat; 2024; 47(6):273-286. PubMed ID: 38636467
[TBL] [Abstract][Full Text] [Related]
5. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38811773
[TBL] [Abstract][Full Text] [Related]
6. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
Zhang M; Wei T; Zhang X; Guo D
Front Immunol; 2022; 13():937406. PubMed ID: 36131916
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy.
Lim SA
BMB Rep; 2024 Jun; ():. PubMed ID: 38919017
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints.
Xu Y; He L; Fu Q; Hu J
Front Oncol; 2021; 11():759015. PubMed ID: 34858835
[TBL] [Abstract][Full Text] [Related]
9. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
11. RNA Modifications in Cancer Metabolism and Tumor Microenvironment.
Qing Y; Wu D; Deng X; Chen J; Su R
Cancer Treat Res; 2023; 190():3-24. PubMed ID: 38112997
[TBL] [Abstract][Full Text] [Related]
12. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.
Wu Y; Pu X; Wang X; Xu M
Lipids Health Dis; 2024 Feb; 23(1):35. PubMed ID: 38302980
[TBL] [Abstract][Full Text] [Related]
15. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
18. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.
Zhao L; Liu Y; Zhang S; Wei L; Cheng H; Wang J; Wang J
Cell Death Dis; 2022 Apr; 13(4):378. PubMed ID: 35444235
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming the tumor microenvironment with biotechnology.
Kim M; Lee NK; Wang CJ; Lim J; Byun MJ; Kim TH; Park W; Park DH; Kim SN; Park CG
Biomater Res; 2023 Jan; 27(1):5. PubMed ID: 36721212
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria.
Bai R; Cui J
Cancer Lett; 2023 Jun; 564():216223. PubMed ID: 37172686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
